Zepbound is also approved to treat severe obstructive sleep apnea (OSA) in adults with obesity. Zepbound can cause mild to serious side effects, but insomnia is not among the side effects reported ...

Obstructive sleep apnea or OSA affects nearly a billion people across the globe. It robs people of their sleep.

"It's called GLP-1 receptor," said Dr. Atul Malhotra from the UC San Diego School of Medicine. It’s already FDA-approved to ...

Compounding pharmacies have been allowed to essentially make a cheaper version of Eli Lilly's Zepbound, but they have to stop ...

The U.S. equity market has had a solid run in the past two years, buoyed by a steadily improving macroeconomic environment ...

Novo Nordisk’s hopes of heralding a new era of obesity treatment with its next-generation CagriSema drug may be in doubt ...

And Jackson doesn't need his sleep apnea machine anymore. (In December, the Food and Drug Administration approved Zepbound to treat sleep apnea.) "It is completely life-changing to take a bite of ...

Eli Lilly and Company (NYSE:LLY) offers a quarterly dividend of $1.50 per share and has a dividend yield of 0.71%, as of March 20. It is one of the best dividend stocks on our list as the company has ...